Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease

Neuropathology and Applied Neurobiology

Volumn 31, Issue 4, 2005, Pages 414-421

  Williams, S ^a   Chalmers, K ^a   Wilcock, G K ^a   Love, Seth ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

A ; Alzheimer's disease; Apolipoprotein E; Cerebral amyloid angiopathy; Neurofibrillary tangles; Tau

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTERIOLE; ARTICLE; BRAIN ARTERY; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEURITE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TEMPORAL LOBE; VASCULAR AMYLOIDOSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; ARTERIES; ARTERIOLES; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; TAU PROTEINS;

EID: 23044510798     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2005.00663.x     Document Type: Article

References (26)

1. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996; 148: 2083-95
2. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-9
3. Chalmers K, Wilcock GK, Love S. APOE ε4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein. Neuropathol Appl Neurobiol 2003; 29: 231-8
4. Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S. APOE promoter, ACE1 and CYP46 polymorphisms and β-amyloid in Alzheimer's disease. Neuroreport 2004; 15: 95-8
5. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998; 153: 725-33
6. Delacourte A, Defossez A, Persuy P, Peers MC. Observation of morphological relationships between angiopathic blood vessels and degenerative neurites in Alzheimer's disease. Virchows Arch A Pathol Anat Histol 1987; 411: 199-204
7. Love S. Contribution of cerebral amyloid angiopathy to Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1-4
8. Vidai R, Calero M, Piccardo P, Farlow MR, Unverzagt FW, Mendez E, Jimenez-Huete A, Beavis R, Gallo G, Gomez-Tortosa E, Ghiso J, Hyman BT, Frangione B, Ghetti B. Senile dementia associated with amyloid β protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-ε4 allele. Acta Neuropathol 2000; 100: 1-12
9. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86
10. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59
11. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thai LJ. The apolipoprotein E ε4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996; 47: 190-6
12. Peers MC, Lenders MB, Defossez A, Delacourte A, Mazzuca M. Cortical angiopathy in Alzheimer's disease: the formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels. Virchows Arch A Pathol Anat Histol 1988; 414: 15-20
13. Weller RO. Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol 1998; 57: 885-94
14. Weller RO, Yow HY, Preston SD, Mazanti I, Nicoll JA. Cerebrovascular disease is a major factor in the failure of elimination of Aβ from the aging human brain: implications for therapy of Alzheimer's disease. Ann N Y Acad Sci 2002; 977: 162-8
15. Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain. Neuropathol Appl Neurobiol 2003; 29: 106-17
16. Thaker U, McDonagh AM, Iwatsubo T, Lendon CL, Pickering-Brown SM, Mann DM. Tau load is associated with apolipoprotein E genotype and the amount of amyloid β protein, Aβ40, in sporadic and familial Alzheimer's disease. Neuropathol Appl Neurobiol 2003; 29: 35-44
17. Boutajangout A, Authelet M, Blanchard V, Touchet N, Tremp G, Pradier L, Brion JP. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1. Neurobiol Dis 2004; 15: 47-60
18. Tomidokoro Y, Harigaya Y, Matsubara E, Ikeda M, Kawarabayashi T, Shirao T, Ishiguro K, Okamoto K, Younkin SG, Shoji M. Brain Aβ amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau. J Pathol 2001; 194: 500-6
19. Kurt MA, Davies DC, Kidd M, Duff K, Howlett DR. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Neurobiol Dis 2003; 14: 89-97
20. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 2003; 24: 1063-70
21. Zubenko GS, Stiffler S, Stabler S, Kopp U, Hughes HB, Cohen BM, Moossy J. Association of the apolipoprotein E ε4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet 1994; 54: 199-205
22. Chen L, Baum L, Ng HK, Chan LY, Pang CP. Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset. Hum Pathol 1999; 30: 1172-7
23. Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM. Presence of the apolipoprotein E type ε4 allele is not associated with neurofibrillary pathology or biochemical changes to tau protein. Dement Geriatr Cogn Disord 1997; 8: 288-95
24. Landen M, Thorsell A, Wallin A, Blennow K. The apolipoprotein E allele ε4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 61: 352-6
25. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Peris TT, Lipsitz LA, Hyman BT. Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Ann Neurol 1996; 39: 62-70
26. Morris CM, Benjamin R, Leake A, McArthur FK, Candy JM, Ince PG, Torvik A, Bjertness E, Edwardson JA. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians. Neurosci Lett 1995; 201: 45-7